Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |